Both in Pharmaceuticals
Lisata Therapeutics vs Lipocine
Over the past year LSTA returned −61.9% and LPCN returned −45.1%; their daily moves had a correlation of -0.01.
LSTA −61.9% LPCN −45.1%Growth of $1, one year, split-adjusted
| Metric | LSTA | LPCN |
|---|---|---|
| Price | $1.06 | $1.51 |
| Market cap | $11.5M | $12.4M |
| Today | +3.92% | +3.42% |
| 1 month | −27.9% | −30.1% |
| 6 months | −67.1% | −34.1% |
| Year to date | −43.0% | −81.2% |
| 1 year | −62.1% | −46.5% |
| Revenue growth (YoY) | −100.0% | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 114.5× | 9.9× |
| Net cash | $10.4M | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 116.7% | 56.7% |
| Short % of float | 0.4% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).